Display options
Share it on

Wideochir Inne Tech Maloinwazyjne. 2017;12(1):37-48. doi: 10.5114/wiitm.2017.66856. Epub 2017 Mar 30.

Evaluation of the results of treatment of morbid obesity by the endoscopic intragastric balloon implantation method.

Wideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques

Wojciech Żurawiński, Dariusz Sokołowski, Karolina Krupa-Kotara, Elżbieta Czech, Krystyn Sosada

Affiliations

  1. Division of Emergency Medicine, Medical University of Silesia in Katowice, Specialist Hospital No. 5 in Sosnowiec, Poland.
  2. Voivodeship Hospital, Opole, Poland.
  3. Division of Cancer Prevention, Faculty of Public Health in Bytom, Medical University of Silesia in Katowice, Poland.
  4. Department of Epidemiology and Biostatistics, Division of Biostatistics, Faculty of Public Health in Bytom, Medical University of Silesia in Katowice, Poland.

PMID: 28446931 PMCID: PMC5397553 DOI: 10.5114/wiitm.2017.66856

Abstract

INTRODUCTION: Overweight and obesity are ranked in the fifth place among the risk factors responsible for the greatest number of deaths in the world.

AIM: To assess the effects of treatment of patients with morbid obesity using endoscopic intragastric balloon (IGB) implantation.

MATERIAL AND METHODS: Two hundred and seventy-two patients with obesity were treated using endoscopic intragastric balloon implantation. Upon analysis of the inclusion and exclusion criteria, the study covered a group of 63 patients with morbid obesity. The patients were implanted with the LexBal balloon. Reduction of excess body mass, changes to BMI values and ailments and complications divided into mild and severe were assessed.

RESULTS: Before intragastric balloon treatment, the average body mass index (BMI) value was 58.3 ±10.5 kg/m

CONCLUSIONS: Endoscopic intragastric balloon implantation is an effective and safe method of excess body mass reduction in patients with morbid obesity before a planned bariatric surgical procedure. Pre-operative excess body mass and BMI value and post-operative excess weight loss in patients with morbid obesity have no impact on frequency of occurrence of ailments and complications in IGB treatment.

Keywords: endoscopy; intragastric balloon; morbid obesity

Conflict of interest statement

The authors declare no conflict of interest.

References

  1. Obes Surg. 2005 Sep;15(8):1161-4 - PubMed
  2. Am Surg. 1990 Oct;56(10):575-80 - PubMed
  3. Obes Surg. 2003 Jun;13(3):329-30 - PubMed
  4. Obes Surg. 2001 Jun;11(3):330-3 - PubMed
  5. Obes Surg. 2000 Feb;10(1):58-60 - PubMed
  6. Br J Surg. 2001 Sep;88(9):1245-8 - PubMed
  7. Eur Radiol. 2001;11(4):588-9 - PubMed
  8. Obes Surg. 2003 Aug;13(4):658-60 - PubMed
  9. Obes Surg. 2004 Aug;14(7):991-8 - PubMed
  10. Wideochir Inne Tech Maloinwazyjne. 2016;11(1):22-25 - PubMed
  11. Wideochir Inne Tech Maloinwazyjne. 2015 Sep;10(3):445-9 - PubMed
  12. Gastrointest Endosc. 1987 Aug;33(4):323-7 - PubMed
  13. Lancet. 1982 Jan 23;1(8265):198-9 - PubMed
  14. Obes Surg. 2010 Sep;20(9):1219-26 - PubMed
  15. Gastrointest Endosc. 2005 Jan;61(1):19-27 - PubMed
  16. Obes Surg. 2005 Apr;15(4):510-6 - PubMed
  17. Obes Surg. 2017 Feb;27(2):536-540 - PubMed
  18. J Transl Med. 2015 Jul 29;13:246 - PubMed
  19. Obes Surg. 2009 Jun;19(6):677-83 - PubMed
  20. Lancet. 2009 Mar 28;373(9669):1083-96 - PubMed
  21. Obes Surg. 2006 May;16(5):667-70 - PubMed
  22. Ann R Coll Surg Engl. 2000 May;82(3):202-4 - PubMed
  23. Gastroenterology. 1988 Sep;95(3):589-92 - PubMed
  24. Acta Chir Belg. 2005 Feb;105(1):40-3 - PubMed
  25. Scand J Gastroenterol. 2002 Nov;37(11):1246-52 - PubMed
  26. Obes Surg. 2000 Dec;10(6):578-81 - PubMed

Publication Types